Next 10 |
home / stock / elmty / elmty news
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Elementis ADR (ELMTY) is expected to report for Q4 2023
2024-01-28 11:40:00 ET Summary Elementis is a specialty chemicals company focusing on personal healthcare and coatings, with a market capitalization of approximately $1.05B. The company's free cash flow profile is strong, with an underlying free cash flow per share of approximatel...
UK-based chemicals company Elementis Plc ( OTCPK:ELMTY ) may be seeing takeover interest from an unidentified suitor amid a strategic review of its Chromium unit. There's speculation that Elementis ( OTCPK:ELMTY ) may be garnering interest from a party who wants to bu...
Elementis is a specialty chemicals manufacturer, supplying different additives to the personal care, premium coatings, automotive and paper industries among others. The company owns valuable assets such as the only high-quality rheology grade hectorite mine in the world. Past debt...
Innospec (IOSP) said it has ceased an offer for chemicals company Elementis PLC (ELMTY) after the company's board rejected the offer on April 9.Innospec offered 160p per Elementis shares with a maxium 50% cash "alternative with mix and match facility," accoding to a statement. Innospec s...
Innospec (IOSP) fell 3.6% on a report that it made a 1B pound bid for chemicals maker Elementis (ELMTY).The bid may have been made with cash and shares and it valued Elementis at more than 200p-a-share, Sky News reported. Developing story ... For further details see: Inno...
Like many others affected directly or indirectly by the current crisis, Elementis ( ELMTY ) PLC has faced numerous headwinds that have pushed the share price significantly below pre-COVID-19 levels. However, even before the company felt the impacts of the crisis, they were struggling. I believ...
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain. Elementis plc ...
4 October 2019 Elementis plc (the “Company”) Directorate change Elementis plc (LSE: ELM), a global specialty chemicals company announces that as part of the Board’s succession planning processes, Nick Salmon has agreed to step down from the Board and not ...
News, Short Squeeze, Breakout and More Instantly...
Elementis Plc ADR Level 1 Company Name:
ELMTY Stock Symbol:
OTCMKTS Market:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Elementis ADR (ELMTY) is expected to report for Q4 2023
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain. Elementis plc ...